Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection : a case report
Date issued
Authors
Kaps, Leonard
Labenz, Christian
Grimm, Daniel
Schwarting, Andreas
Galle, Peter R.
Schreiner, Oliver
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
License
Abstract
The biological anakinra appears promising to halt cytokine storm syndrome seen in severe courses of COVID‐19. However, immunosuppression with anakinra may facilitate sepsis, necessitating continuous screening for bacterial superinfections.